Surmodics, Inc’s filing revealed that its Chief Financial Officer Arens Timothy J. unloaded Company’s shares for reported $0.28 million on Nov 26 ’24. In the deal valued at $39.44 per share,7,009 shares were sold. As a result of this transaction, Arens Timothy J. now holds 70,350 shares worth roughly $2.79 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, TIMOTHY ARENS bought 7,009 shares, generating $276,453 in total proceeds.
Needham upgraded its Surmodics, Inc [SRDX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in mid February from “a Buy” to “a Hold”. Needham also remained covering SRDX and has increased its forecast on July 23, 2020 with a “Buy” recommendation from previously “Hold” rating. Needham revised its rating on December 11, 2019. It rated SRDX as “a Hold” which previously was an “a Buy”.
Price Performance Review of SRDX
On Tuesday, Surmodics, Inc [NASDAQ:SRDX] saw its stock jump 0.40% to $39.68. Over the last five days, the stock has lost -0.70%. Surmodics, Inc shares have risen nearly 9.16% since the year began. Nevertheless, the stocks have risen 7.39% over the past one year. While a 52-week high of $42.44 was reached on 07/09/24, a 52-week low of $25.17 was recorded on 04/30/24. SMA at 50 days reached $38.94, while 200 days put it at $37.19.
Levels Of Support And Resistance For SRDX Stock
The 24-hour chart illustrates a support level at 39.54, which if violated will result in even more drops to 39.41. On the upside, there is a resistance level at 39.79. A further resistance level may holdings at 39.91. The Relative Strength Index (RSI) on the 14-day chart is 53.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.95%. Stochastics %K at 35.56% indicates the stock is a holding.
How much short interest is there in Surmodics, Inc?
A steep rise in short interest was recorded in Surmodics, Inc stocks on 2024-11-29, growing by 6889.0 shares to a total of 0.34 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 0.33 million shares. There was a rise of 2.04%, which implies that there is a positive sentiment for the stock.
